» Articles » PMID: 28959637

Depsidones Inhibit Aromatase Activity and Tumor Cell Proliferation in a Co-culture of Human Primary Breast Adipose Fibroblasts and T47D Breast Tumor Cells

Overview
Journal Toxicol Rep
Date 2017 Sep 30
PMID 28959637
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Naturally occurring depsidones from the marine fungus are known to have substantial anti-cancer activity, but their mechanism of action remains elusive. The purpose of this study was to examine the anti-aromatase activity of two common depsidones, unguinol and aspergillusidone A, in a co-culture system of human primary breast adipose fibroblasts and hormonal responsive T47D breast tumor cells. Using this model it was shown that these depsidones inhibit the growth of T47D tumor cells most likely via inhibition of aromatase (CYP19) activity. The IC values of these depisidones were compared with the aromatase inhibitors letrozole and exemestane. Letrozole and exemestane had IC values of respectively, 0.19 and 0.14 μM, while those for Unguinol and Aspergillusidone A were respectively, 9.7 and 7.3 μM. Our results indicate that among the depsidones there maybe aromatase inhibitors with possible pharmacotherapeutical relevance.

Citing Articles

Secondary Metabolites Diversity of and Their Bioactivities: A Potential Target to Be Explored.

Domingos L, Martins R, Lima L, Ghizelini A, Ferreira-Pereira A, Cotinguiba F Biomolecules. 2022; 12(12).

PMID: 36551248 PMC: 9775040. DOI: 10.3390/biom12121820.


Evaluation of anti-tumour properties of two depsidones - Unguinol and Aspergillusidone D - in triple-negative MDA-MB-231 breast tumour cells.

Zwartsen A, Chottanapund S, Kittakoop P, Navasumrit P, Ruchirawat M, van Duursen M Toxicol Rep. 2019; 6:1216-1222.

PMID: 31788435 PMC: 6880138. DOI: 10.1016/j.toxrep.2019.10.012.


Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Rendic S, Guengerich F Drug Metab Rev. 2019; 50(3):256-342.

PMID: 30717606 PMC: 6421578. DOI: 10.1080/03602532.2018.1483401.


Essential oil from as the potential inhibitor for HSP90.

Gaonkar R, Shiralgi Y, Lakkappa D, Hegde G Toxicol Rep. 2018; 5:489-496.

PMID: 29854620 PMC: 5978008. DOI: 10.1016/j.toxrep.2018.03.014.

References
1.
Sonne-Hansen K, Lykkesfeldt A . Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line. J Steroid Biochem Mol Biol. 2005; 93(1):25-34. DOI: 10.1016/j.jsbmb.2004.11.005. View

2.
Bosch A, Eroles P, Zaragoza R, Vina J, Lluch A . Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research. Cancer Treat Rev. 2010; 36(3):206-15. DOI: 10.1016/j.ctrv.2009.12.002. View

3.
Heneweer M, Muusse M, Dingemans M, de Jong P, van den Berg M, Sanderson J . Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model. Toxicol Sci. 2004; 83(2):257-63. DOI: 10.1093/toxsci/kfi025. View

4.
Fauss J, Pyerin W . Rapid assay of aromatase activity by fast liquid chromatography: spectroscopic evaluation of metabolite profiles indicate unexpected pitfalls. Anal Biochem. 1993; 210(2):421-3. DOI: 10.1006/abio.1993.1218. View

5.
Lu D, Kiriyama Y, Lee K, Giguere V . Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors. Cancer Res. 2001; 61(18):6755-61. View